Incyte Corporation
Drug discovery company announces 2004 financial results, provides 2005 guidance
Published in Drug Law Weekly, March 22nd, 2005
Total revenues for the fourth quarter and full year ended December 31, 2004, were $2.3 million and $14.1 million, respectively, as compared to $9.0 million in the fourth quarter of 2003 and $41.2 million for the year ending December 31, 2003.
The company's net loss for the fourth quarter and full year 2004 was $37.5 million, or $0.47 per share and $164.8 million, or $2.21 per share, respectively.
The fourth quarter 2004 loss includes a charge of $12.1 million to adjust the carrying value of previously capitalized costs associated with the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2005-03-22)
More Articles from Drug Law Weekly
- Cancer Therapy
Study shows patients get more benefit than thought from early cancer treatment - Cylacel Group
U.S. patent granted for cyclin dependent kinase inhibitor series - Emory University, Atlanta
Factors associated with victimization of African American female DUs identified - HIV/AIDS Testing
Expectant mothers urged to get tested for AIDS - Healthcare Fraud
Doctor indicted again on healthcare fraud charges - Market Strategies, Inc.
Consulting company reports Medicare reform changing oncology practices - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
